Precision Imaging to Evaluate Kaposi Sarcoma
Recruiting · NCT06898203 · Interventional (participants receive a specific treatment) · Lead sponsor: Washington University School of Medicine
View the official record on ClinicalTrials.gov →Interventions studied
SkinScan3D
What this trial is about
AIMS 2 \& 3: In this study the investigators seek to formally compare reproducibility and accuracy of KS lesion size measurements between SkinScan3D and the current standard of care manual measurement method. The investigators will then test the SS3D device on 100 patients in a variety of real-world practice locations to determine whether the device will be usable, acceptable, appropriate, and feasible in routine care settings.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Aim 2 (Patients):
- Adults age ≥18 years old
- Histopathology-confirmed Kaposi Sarcoma
- At least 3 skin lesions
- Capable of informed consent
- On treatment for Kaposi Sarcoma
Exclusion criteria
- Aim 2 (Patients):
- Patients not initiating Kaposi Sarcoma treatment
- Very ill patients requiring hospitalization
- Inclusion Criteria - Aim 3 (Patients):
- Adults age ≥18 years old
- Histopathology-confirmed Kaposi Sarcoma
- Capable of informed consent
- Initiating treatment for Kaposi Sarcoma
- Exclusion Criteria - Aim 3 (Patients):
- Patients with Kaposi Sarcoma that participated in Aim 1 or Aim 2
- Prior or ongoing Kaposi Sarcoma treatment
Where it is running
2 locations listed.
- Infectious Diseases Institute, Makerere University - Kampala, Uganda
- Kenya Medical Research Institute - Kisumu, Kenya